|
Astrocytoma
|
|
|
|
Jeffrey
G Supko, Xiaoying He, Carolyn Whitney, Tracy Batchelor, Thomas
Mikkelsen, Jane Alavi, Surasak Phuphanich, Stuart Grossman
Pharmacokinetics
of procarbazine and metabolites involved in its bioactivation in patients
with recurrent anaplastic astrocytoma
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
Abstract No.
2086
|
|
|
Glioblastoma
|
|
|
|
Alba
Ariela Brandes, Mario Ermani, Umberto Basso, Lara Maria Pasetto, Francesca
Vastola, Franco Berti, Silvia Berlucchi, Pietro Amistà, Antonello Rotilio,
Silvio Monfardini
Procarbazine
Prior to and Concomitant with BCNU in Patients with Glioblastoma at First
Relapse: a Phase II Study
ASCO
Proceedings, 2001 Annual Meeting, Abstract
|
|
R
Albright, M Brada, J Brunner, MH Dugan, K Fink, R Fredericks, VA Levin, J
Olson,
M Prados, A Spence, N Yue, A Yung, S Zaknoen
Randomized Trial of Temodal
(TEM) Vs. Procarbazine (PCB) in Glioblastoma
Multiforme (GBM) at First Relapse
ASCO Proceedings, 1999 Annual Meeting, Abstract
|
|
|
Osoba D, Brada M, Yung WK, Prados M.
Health-related quality of life in patients
treated with temozolomide versus procarbazine for recurrent glioblastoma
multiforme
J Clin Oncol
2000 Apr;18(7):1481-91 (PDF Full Text)
|
|
|
Antonio Silvani, Elena Lamperti, Paola Gaviani,
Marica Eoli, Anna Fiumani, Andrea Salmaggi, Chiara Falcone,
Graziella Filippini, Andrea Botturi and Amerigo Boiardi
Salvage chemotherapy with procarbazine and fotemustine combination in the
treatment of temozolomide treated recurrent glioblastoma patients
Journal of Neuro-Oncology, Epub June 19, 2007, DOI:
10.1007/s11060-007-9427-y
Abstract |
Reprint
| 
DBLinks | BL 7:4
|
|
|
Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence
A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selker RG, Vick NA, Rampling R,
Friedman H, Phillips P, Bruner J, Yue N, Osoba D, Zaknoen S, Levin VA.
A
phase II study of temozolomide vs. procarbazine in patients with glioblastoma
multiforme at first relapse
Br J
Cancer 2000 Sep;83(5):588-93
|
|
|
Gliomas
|
|
|
|
Beith
J., Cook R., Robinson B., Levi J., Bell D., Wheeler H.
Modulation of resistance to BCNU by depleting
MGMT activity with procarbazine in patients with relapsed high-grade
gliomas
ASCO
Proceedings, 1997 Annual Meeting, Abstract No. 1375
|
|
Boiardi A, Silvani A, Ciusani
E, Watson A, Margison G, Berger E, Lucas C, Giroux B
Fotemustine combined with procarbazine in
recurrent malignant gliomas: a phase I study with evaluation of
lymphocyte 06-alkylguanine-DNA alkyltransferase activity
J Neurooncol 2001 Apr;52(2):149-56
|
|
Brandes AA, Ermani M, Turazzi S,
Scelzi E, Berti F, Amista P, Rotilio A, Licata C, Fiorentino MV
Procarbazine and high-dose tamoxifen as a second-line
regimen in recurrent high-grade gliomas: a phase II study
J Clin Oncol 1999
Feb;17(2):645-50 (PDF Full Text)
|
|
Newlands
ES, Foster T, Zaknoen S
Phase
I study of temozolomide (TMZ) combined with procarbazine (PCB) in patients
with gliomas
Br J Cancer. 2003 Jul 21;89(2):248-51.
|
|
Slancar
M., Wheeler H., Cook R., Levi J., Bell D., Beith J.
Increased pulmonary toxicity with scheduling
procarbazine prior to BCNU in patients with high-grade gliomas
ASCO
Proceedings, 1997 Annual Meeting, Abstract No. 1459
|
|
|
Gliomas
(High Grade)
|
|
|
|
Dufour C, Grill J, Lellouch-Tubiana A, Puget S, Chastagner
P, Frappaz D, Doz F, Pichon F, Plantaz D, Gentet
JC, Raquin MA, Kalifa C.
High-grade glioma in children under 5 years of age: A
chemotherapy only approach with the BBSFOP protocol.
Eur J Cancer.
2006 Sep 6; [Epub ahead of print]
Abstract
|
|
|
|
